AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 64 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $285,000 | -20.6% | 40,190 | +3.6% | 0.00% | -33.3% |
Q2 2020 | $359,000 | +223.4% | 38,804 | +63.3% | 0.01% | +100.0% |
Q1 2020 | $111,000 | -69.8% | 23,763 | -50.7% | 0.00% | +50.0% |
Q4 2019 | $368,000 | -32.5% | 48,222 | -31.9% | 0.00% | -60.0% |
Q3 2019 | $545,000 | +50.6% | 70,861 | +34.0% | 0.01% | +25.0% |
Q2 2019 | $362,000 | +16.0% | 52,864 | +36.4% | 0.00% | +33.3% |
Q1 2019 | $312,000 | -29.9% | 38,752 | -34.8% | 0.00% | -40.0% |
Q4 2018 | $445,000 | -34.9% | 59,443 | -16.9% | 0.01% | -37.5% |
Q3 2018 | $684,000 | +95.4% | 71,500 | +116.0% | 0.01% | +60.0% |
Q2 2018 | $350,000 | +233.3% | 33,108 | +212.3% | 0.01% | +150.0% |
Q1 2018 | $105,000 | +15.4% | 10,600 | -13.1% | 0.00% | -33.3% |
Q1 2017 | $91,000 | – | 12,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $50,420 | 0.68% |
Aisling Capital Management LP | 1,691,151 | $761,018 | 0.50% |
Sio Capital Management, LLC | 3,004,959 | $1,351,931 | 0.50% |
Bain Capital Life Sciences Investors, LLC | 5,347,689 | $2,406 | 0.27% |
Ghost Tree Capital, LLC | 800,000 | $360,000 | 0.15% |
Nantahala Capital Management | 4,611,302 | $2,074,625 | 0.13% |
Samsara BioCapital, LLC | 883,720 | $397,586 | 0.09% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $1,826,546 | 0.08% |
SPHERA FUNDS MANAGEMENT LTD. | 440,837 | $198,333 | 0.04% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $111 | 0.04% |